| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | REYNOLDS AMERICAN INC | 15,196,113 | 764,516,000 | 34.92% | ||
| 2 | ABBVIE INC | 11,063,300 | 631,936,000 | 28.87% | ||
| 3 | PROTHENA CORP PLC | 9,296,361 | 382,638,000 | 17.48% | ||
| 4 | ALKERMES PLC SHS | 7,131,533 | 243,827,000 | 11.14% | ||
| 5 | Theravance Biopharma Inc | 6,824,637 | 128,303,000 | 5.86% | ||
| 6 | NORTHWEST BIOTHERAPEUTICS INC | 25,915,937 | 37,837,000 | 1.73% |
Portfolio data is normalized using SEC Form 13F filings, including the Restatement filing (0001213900-17-005682, filed 2017.05.22).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
